Wu Yan, Guo Sun-Wei
Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road, MS 756, Milwaukee, WI 53226-0509, USA.
Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):88-93. doi: 10.1016/j.ejogrb.2006.07.034. Epub 2007 Feb 12.
Over-production of cyclooxygenase-2 (COX-2) plays an important role in the positive feedback loop that leads to proliferation and inflammation in endometriosis. Following our observation that histone deacetylase inhibitors (HDACIs) trichostatin A (TSA) and valproic acid (VPA) can suppress proliferation of endometrial stromal cells, we sought to determine whether TSA suppresses IL-1beta-induced COX-2 expression in endometrial stromal cells.
In vitro study using a recently established immortalized endometrial stromal cell line. The stromal cells were pretreated with TSA before stimulation with IL-1beta, and COX-2 gene and protein expression was measured by real-time quantitative RT-PCR and Western blot analysis, respectively.
IL-1beta stimulated COX-2 expression in a concentration-dependent manner in endometrial stromal cells. The induced COX-2 gene and protein expression were suppressed by TSA pretreatment.
TSA suppresses IL-1beta-induced COX-2 gene and protein expression in endometrial stromal cells. This finding, coupled with the findings that TSA and another HDACI, valproic acid, suppress proliferation and induce cell cycle arrest, suggests that HDACIs are a promising class of compound that has therapeutic potential for endometriosis.
环氧合酶-2(COX-2)的过度产生在导致子宫内膜异位症增殖和炎症的正反馈回路中起重要作用。在我们观察到组蛋白去乙酰化酶抑制剂(HDACIs)曲古抑菌素A(TSA)和丙戊酸(VPA)可抑制子宫内膜基质细胞增殖后,我们试图确定TSA是否能抑制白细胞介素-1β(IL-1β)诱导的子宫内膜基质细胞中COX-2的表达。
使用最近建立的永生化子宫内膜基质细胞系进行体外研究。在用IL-1β刺激之前,用TSA预处理基质细胞,分别通过实时定量逆转录聚合酶链反应(RT-PCR)和蛋白质印迹分析测量COX-2基因和蛋白表达。
IL-1β以浓度依赖的方式刺激子宫内膜基质细胞中COX-2的表达。TSA预处理可抑制诱导的COX-2基因和蛋白表达。
TSA可抑制IL-1β诱导的子宫内膜基质细胞中COX-2基因和蛋白表达。这一发现,再加上TSA和另一种HDACI丙戊酸可抑制增殖并诱导细胞周期停滞的发现,表明HDACIs是一类有前景的化合物,对子宫内膜异位症具有治疗潜力。